Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care.


Abstract Annual influenza epidemics cause substantial morbidity and mortality, and the majority of patients with influenza-like illness present to primary care. Point-of-care influenza tests could support treatment decisions. It is critical to establish analytic performance of these platforms in real-life patient samples before uptake can be considered. We aimed […]

Click here to view original web page at